FibroGen, Inc. (0IL8.L)

USD 0.36

(3.62%)

Inventory Summary of FibroGen, Inc.

  • FibroGen, Inc.'s latest annual inventory in 2023 was 41.56 Million USD , up 2.79% from previous year.
  • FibroGen, Inc.'s latest quarterly inventory in 2024 Q1 was 27.33 Million USD , down -34.24% from previous quarter.
  • FibroGen, Inc. reported annual inventory of 40.43 Million USD in 2022, up 30.38% from previous year.
  • FibroGen, Inc. reported annual inventory of 31.01 Million USD in 2021, up 87.63% from previous year.
  • FibroGen, Inc. reported quarterly inventory of 27.33 Million USD for 2024 Q1, down -34.24% from previous quarter.
  • FibroGen, Inc. reported quarterly inventory of 41.17 Million USD for 2023 Q2, down -3.01% from previous quarter.

Annual Inventory Chart of FibroGen, Inc. (2023 - 2012)

Historical Annual Inventory of FibroGen, Inc. (2023 - 2012)

Year Inventory Inventory Growth
2023 41.56 Million USD 2.79%
2022 40.43 Million USD 30.38%
2021 31.01 Million USD 87.63%
2020 16.53 Million USD 140.02%
2019 6.88 Million USD 688699900.0%
2018 1.00 USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 1.00 USD 0.0%
2014 1.00 USD 0.0%
2013 - USD -100.0%
2012 1.00 USD 0.0%

Peer Inventory Comparison of FibroGen, Inc.

Name Inventory Inventory Difference
Editas Medicine, Inc. - USD -Infinity%
Dynavax Technologies Corporation 53.29 Million USD 22.002%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 46.304%
Perrigo Company plc 1.14 Billion USD 96.357%
Illumina, Inc. 587 Million USD 92.919%
Thermo Fisher Scientific Inc. 5.08 Billion USD 99.183%
Iovance Biotherapeutics, Inc. 10.37 Million USD -300.742%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.5%
IQVIA Holdings Inc. - USD -Infinity%
Heron Therapeutics, Inc. 42.11 Million USD 1.294%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 98.389%
Unity Biotechnology, Inc. - USD -Infinity%
Waters Corporation 516.23 Million USD 91.948%
Biogen Inc. 2.52 Billion USD 98.355%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -277.932%
Adicet Bio, Inc. - USD -Infinity%
Cara Therapeutics, Inc. 2.82 Million USD -1373.414%
bluebird bio, Inc. 22.91 Million USD -81.356%
Esperion Therapeutics, Inc. 65.62 Million USD 36.661%
Agilent Technologies, Inc. 1.03 Billion USD 95.968%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 53.374%
Amicus Therapeutics, Inc. 59.69 Million USD 30.372%
Myriad Genetics, Inc. 20.1 Million USD -106.791%
Viking Therapeutics, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 98.379%
Abeona Therapeutics Inc. -2.44 Million USD 1800.696%
Mettler-Toledo International Inc. 385.86 Million USD 89.228%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 96.246%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 94.374%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD -46.227%
Atara Biotherapeutics, Inc. 9.7 Million USD -328.24%
Verastem, Inc. - USD -Infinity%
Nektar Therapeutics 16.1 Million USD -158.152%
Axsome Therapeutics, Inc. 15.13 Million USD -174.628%
Aclaris Therapeutics, Inc. - USD -Infinity%
Sarepta Therapeutics, Inc. 322.85 Million USD 87.126%
OPKO Health, Inc. 65.69 Million USD 36.732%
Exelixis, Inc. 17.32 Million USD -139.941%
Neurocrine Biosciences, Inc. 38.3 Million USD -8.525%
Corcept Therapeutics Incorporated 7.73 Million USD -437.71%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 12.02 Million USD -245.684%
Imunon, Inc. - USD -Infinity%
Blueprint Medicines Corporation 21.22 Million USD -95.849%
Insmed Incorporated 83.24 Million USD 50.071%
Halozyme Therapeutics, Inc. 127.6 Million USD 67.426%
Agios Pharmaceuticals, Inc. 19.07 Million USD -117.892%
TG Therapeutics, Inc. 39.82 Million USD -4.374%
Incyte Corporation 62.97 Million USD 33.994%
Emergent BioSolutions Inc. 328.9 Million USD 87.362%